 In the quest to ameliorate the camptothecin downsides we expedite to search for stable non CPT analogues among 11 motifs of pyrazoloquinazolines reported . E pharmacophore drug design approach helped filtering out pyrazolo 1 5

@highlight Non camptothecin analogues among 11 motifs of pyrazoloquinazolines are reported.
@highlight E pharmacophore drug design guided discovery of Topoisomerase I inhibitors.
@highlight Topoisomerase I inhibitors induced apoptosis and were non DNA intercalators.
@highlight emerged as a dual inhibitor of Topoisomerase I HDAC1 with potentiated anticancer effect.
